- Filed
- May 30, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · May 29, 2025 | 385.05M sh |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $11.24M |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $4.62M |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $11.37M |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $4.8M |
| Current Assets | Q3 2025 · Mar 31, 2025 | $11.76M |
| Current Assets | Q3 2025 · Jun 30, 2024 | $11.35M |
| Total Assets | Q3 2025 · Mar 31, 2025 | $17.23M |
| Total Assets | Q3 2025 · Jun 30, 2024 | $12.48M |
| Net Income | Q3 2025 · Jun 30, 2024 | −$7.06M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$2.23M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$6.39M |
| Net Income | Q3 2025 · Dec 31, 2023 | −$628.28K |
| Net Income | Q3 2025 · Sep 30, 2023 | −$3.53M |
| Stockholders Equity | Q3 2025 · Jun 29, 2024 | $8.75M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $499.28K |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $2.23M |
| Stockholders Equity | Q3 2025 · Sep 30, 2023 | $2.35M |
| Stockholders Equity | Q3 2025 · Jun 30, 2023 | $5.88M |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 301.99M sh |
| Shares Diluted restated | Q3 2025 · Mar 31, 2024 | 133.16M sh |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | $10.88K |
| Eps Diluted restated | Q3 2025 · Mar 31, 2024 | $0.00 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | −$0.02 |
| Eps Basic restated | Q3 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | −$0.02 |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $2.23M |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $6.4M |
| Operating Income | Q3 2025 · Mar 31, 2024 | −$2.23M |
| Operating Income | Q3 2025 · Mar 31, 2024 | −$6.39M |
| Revenue | Q3 2025 · Mar 31, 2024 | $8.15K |
| Revenue | Q3 2025 · Mar 31, 2024 | $42.05K |